Hibiscus BioVentures, through its subsidiaries, Hibiscus Capital Management and Orchid Bioventures, is dedicated to supporting development- stage life science companies and investors in obtaining the technology, capital, and people necessary to commercialize innovative therapeutics for patients with unmet needs.
A biotechnology and pharmaceutical venture studio focused on partnering with companies and supporting them at every step of their life cycle across a wide range of disciplines, including corporate development, technology sourcing and acquisition, licensing, financing support and M&A.
Providing funding in several core focus areas, including re-building existing businesses and building new companies that have promising, commercially viable technology. Our ultimate goal is advancing novel therapeutic and diagnostic approaches for patients with unmet needs.
Working with Partners to support the 3 Pillars of Successful Biotechnology Companies: Technology, Capital, People.
We want to partner with companies that have transformative technologies that have the potential to greatly impact patient care but may require strategic repositioning, capital or resources to progress.